133 related articles for article (PubMed ID: 30328263)
1. FGF21 decreases food intake and body weight in obese Göttingen minipigs.
Christoffersen B; Straarup EM; Lykkegaard K; Fels JJ; Sass-Ørum K; Zhang X; Raun K; Andersen B
Diabetes Obes Metab; 2019 Mar; 21(3):592-600. PubMed ID: 30328263
[TBL] [Abstract][Full Text] [Related]
2. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
[TBL] [Abstract][Full Text] [Related]
3. Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs.
Christoffersen BØ; Skyggebjerg RB; Bugge A; Kirk RK; Vestergaard B; Uldam HK; Fels JJ; Pyke C; Sensfuss U; Sanfridson A; Clausen TR
Int J Obes (Lond); 2020 Feb; 44(2):447-456. PubMed ID: 31175319
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.
Sarruf DA; Thaler JP; Morton GJ; German J; Fischer JD; Ogimoto K; Schwartz MW
Diabetes; 2010 Jul; 59(7):1817-24. PubMed ID: 20357365
[TBL] [Abstract][Full Text] [Related]
5. PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates.
Thompson WC; Zhou Y; Talukdar S; Musante CJ
J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):411-25. PubMed ID: 27405817
[TBL] [Abstract][Full Text] [Related]
6. Influence of castration-induced testosterone and estradiol deficiency on obesity and glucose metabolism in male Göttingen minipigs.
Christoffersen BO; Gade LP; Golozoubova V; Svendsen O; Raun K
Steroids; 2010 Oct; 75(10):676-84. PubMed ID: 20420845
[TBL] [Abstract][Full Text] [Related]
7. Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice.
Camacho RC; Zafian PT; Achanfuo-Yeboah J; Manibusan A; Berger JP
Eur J Pharmacol; 2013 Sep; 715(1-3):41-5. PubMed ID: 23831019
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
9. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.
Véniant MM; Komorowski R; Chen P; Stanislaus S; Winters K; Hager T; Zhou L; Wada R; Hecht R; Xu J
Endocrinology; 2012 Sep; 153(9):4192-203. PubMed ID: 22798348
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
Weng Y; Chabot JR; Bernardo B; Yan Q; Zhu Y; Brenner MB; Vage C; Logan A; Calle R; Talukdar S
PLoS One; 2015; 10(3):e0119104. PubMed ID: 25790234
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs.
Renner S; Blutke A; Dobenecker B; Dhom G; Müller TD; Finan B; Clemmensen C; Bernau M; Novak I; Rathkolb B; Senf S; Zöls S; Roth M; Götz A; Hofmann SM; Hrabĕ de Angelis M; Wanke R; Kienzle E; Scholz AM; DiMarchi R; Ritzmann M; Tschöp MH; Wolf E
Mol Metab; 2018 Oct; 16():180-190. PubMed ID: 30017782
[TBL] [Abstract][Full Text] [Related]
12. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
[TBL] [Abstract][Full Text] [Related]
13. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.
Talukdar S; Zhou Y; Li D; Rossulek M; Dong J; Somayaji V; Weng Y; Clark R; Lanba A; Owen BM; Brenner MB; Trimmer JK; Gropp KE; Chabot JR; Erion DM; Rolph TP; Goodwin B; Calle RA
Cell Metab; 2016 Mar; 23(3):427-40. PubMed ID: 26959184
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effect of fibroblast growth factor 21 on hypertension induced by insulin resistance].
Zhu SL; Ren GP; Zhang ZY; Wang WF; Ye XL; Han MM; Zhao JZ; Xu TY; Liu MY; Li DS
Yao Xue Xue Bao; 2013 Sep; 48(9):1409-14. PubMed ID: 24358774
[TBL] [Abstract][Full Text] [Related]
15. FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats.
Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Wang X; Liang G; Li X; Jiang C; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Biomed Pharmacother; 2018 Jan; 97():1663-1672. PubMed ID: 29793329
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide, a once-daily human glucagon-like peptide-1 analog, minimizes food intake in severely obese minipigs.
Raun K; von Voss P; Knudsen LB
Obesity (Silver Spring); 2007 Jul; 15(7):1710-6. PubMed ID: 17636089
[TBL] [Abstract][Full Text] [Related]
18. The young Göttingen minipig as a model of childhood and adolescent obesity: influence of diet and gender.
Christoffersen B; Golozoubova V; Pacini G; Svendsen O; Raun K
Obesity (Silver Spring); 2013 Jan; 21(1):149-58. PubMed ID: 23505180
[TBL] [Abstract][Full Text] [Related]
19. Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats.
Wang WF; Li SM; Ren GP; Zheng W; Lu YJ; Yu YH; Xu WJ; Li TH; Zhou LH; Liu Y; Li DS
Endocrine; 2015 May; 49(1):119-29. PubMed ID: 25306889
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Andersen B; Omar BA; Rakipovski G; Raun K; Ahrén B
Eur J Pharmacol; 2015 Oct; 764():189-194. PubMed ID: 26144370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
